Bicifadine
Bicifadine (DOV-220,075) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) discovered at American Cyanamid as an analgesic drug candidate, and licensed to DOV Pharmaceutical in 1998 after American Cyanamid was acquired by Wyeth.
primaryTopic
Bicifadine
Bicifadine (DOV-220,075) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) discovered at American Cyanamid as an analgesic drug candidate, and licensed to DOV Pharmaceutical in 1998 after American Cyanamid was acquired by Wyeth.
has abstract
Bicifadine (DOV-220,075) is a ...... r "triple reuptake inhibitor."
@en
ATC prefix
CAS number
71195-57-8
FDA UNII code
B0SV3N7J3H
IUPAC name
1-(4-Methylphenyl)-3-azabicyclo[3.1.0]hexane
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
14,724,536
Wikipage revision ID
713,196,126
ChEMBL
ChemSpiderID
elimination half-life
excretion
legal US
molecular weight
routes of administration
smiles
c1cc[C@]32CNC[C@@H]2C3
StdInChIKey
OFYVIGTWSQPCLF-NWDGAFQWSA-N
Verifiedfields
verifiedrevid
462,798,006
Watchedfields
hypernym
comment
Bicifadine (DOV-220,075) is a ...... yanamid was acquired by Wyeth.
@en
label
Bicifadine
@en
